Clexane and Haemolytic anaemia - a phase IV clinical study of FDA data

Summary:

Haemolytic anaemia is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Cordarone, and have Diabetes.

The phase IV clinical study analyzes which people have Haemolytic anaemia when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Haemolytic anaemia?

Haemolytic anaemia (anaemia due to haemolysis) is found to be associated with 779 drugs and 1,045 conditions by eHealthMe. Check the latest studies of Haemolytic anaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 16 people (0.11%) have Haemolytic anaemia.

Among these 16 people:

How long have people been on Clexane when they have Haemolytic anaemia? *

What is the gender of people who have Haemolytic anaemia when taking Clexane? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Haemolytic anaemia when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Haemolytic anaemia? *

Hypotension (abnormally low blood pressure): 9 people, 56.25%
Blood Creatinine Increased: 9 people, 56.25%
Urine Output - Decreased: 8 people, 50.00%
Creatinine Renal Clearance Decreased: 8 people, 50.00%
Hyperchloraemia (an excess of chlorides in the blood): 8 people, 50.00%
Thrombocytopenia (decrease of platelets in blood): 8 people, 50.00%
Hepatitis Fulminant (life-threatening condition defined by significantly impaired liver function): 8 people, 50.00%
Haemoglobin Decreased: 8 people, 50.00%
Drug Level Above Therapeutic: 8 people, 50.00%
Bradycardia (abnormally slow heart action): 8 people, 50.00%

What are the existing conditions these people have? *

Diabetes: 8 people, 50.00%
Klebsiella Infection: 7 people, 43.75%
Stenotrophomonas Infection: 5 people, 31.25%
Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 31.25%
Serratia Infection (bacterial infection): 5 people, 31.25%
Proteus Infection (proteus can cause urinary tract infections): 5 people, 31.25%
Hepatitis B: 5 people, 31.25%
Nosocomial Infection (infection from hospital): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Haemolytic anaemia?

- Check whether Haemolytic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemolytic anaemia:

Haemolytic anaemia (779 drugs)

Browse all the conditions that are associated with Haemolytic anaemia:

Haemolytic anaemia (1,045 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.